Amyris, Inc. (NASDAQ:AMRS) Receives Consensus Rating of "Buy" from Analysts

Retrieved on: 2021-07-01 07:30:00

Tags for this article:

Click the tags to see associated articles and topics

Amyris, Inc. (NASDAQ:AMRS) Receives Consensus Rating of "Buy" from Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 11,955,865 shares of the biotechnology company's stock valued at $228,358,000 after acquiring an additional 3,510,892 ...

Article found on: www.marketbeat.com